FindTrial
Sign In

The Economic Burden and Quality of Life of Pulmonary Arterial Hypertension Patients

The Economic Burden and Quality of Life of Pulmonary Arterial Hypertension Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047926
Enrollment
Unknown
Registered
2021-06-27
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary arterial hypertension

Interventions

Case series:none

Sponsors

Second Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged > 14 years; 2. Previous right heart catheterization, in line with the PAH right heart catheterization standard: mPAP>=25mmHg, and PAWP3wood; 3. Clear awareness and informed consent.

Exclusion criteria

Exclusion criteria: 1. Pulmonary hypertension other than the first category; 2. Severe liver and kidney failure, malignant tumor and severe physical dysfunction that affect the survey results; 3. Participate in a trial study of a targeted drug for pulmonary arterial hypertension.

Design outcomes

Primary

MeasureTime frame
Economic burden;Chinese version Emphasis-10 pulmonary arterial hypertension specificity scale;6 minutes walking distance;Brain natriuretic peptide precursor;Echocardiography;Right heart catheterization;—

Countries

China

Contacts

Public ContactLi Jiang
lijiangcs@csu.edu.cn+86 13975128898

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026